Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 11, 2008, Pages 1425-1432

  Mangiavacchi, Maurizio ^a   Gasparini, Maurizio ^a   Genovese, Stefano ^a   Pini, Daniela ^a   Klersy, Catherine ^b   Bragato, Renato ^a   Andreuzzi, Bruno ^a   Municinò, Annamaria ^a   Regoli, François ^a   Galimberti, Paola ^a   Ceriotti, Carlo ^a   Gronda, Edoardo ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Cardiac resynchronization therapy; Diabetes mellitus; Heart failure; Insulin treatment

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; SURVIVAL RATE; WALKING;

AGED; CARDIAC PACING, ARTIFICIAL; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; INSULIN; ITALY; MALE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 53749094003     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.01206.x     Document Type: Article

References (24)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, et al. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006 113 : e85 e151.
2. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham study. J Am Coll Cardiol 1993 22 : 6A 13A.
3. Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 2001 38 : 421 428.
4. Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P, Kober L, Torp-Pedersen C. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 2004 43 : 771 777.
5. Smooke S, Horwich TB, Fonarow GC. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. Am Heart J 2005 149 : 168 174.
6. Hoppe UC, Freemantle N, Cleland JGF, Marijianowski M, Erdmann E. Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure. Diabetes Care 2007 30 : 722 724.
7. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002 346 : 1845 1853.
8. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 : 1539 1549.
9. Dupuis JM, Kobeissi A, Vitali L, Gaggini G, Merheb M, Rouleau F, Leftheriotis G, et al. Programming optimal atrioventricular delay in dual chamber pacing using peak endocardial acceleration: Comparison with a standard echocardiographic procedure. Pacing Clin Electrophysiol 2003 26 : 210 213.
10. Kiès P, Bax JJ, Molhoek SG, Bleeker GB, Boersma E, Stendijk P, Van Der Wall EE, et al. Comparison of effectiveness of cardiac resynchronization therapy in patients with versus without diabetes mellitus. Am J Cardiol 2005 96 : 108 111.
11. Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, et al. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. J Cardiac Fail 2007 13 : 769 773.
12. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJV, Swedberg KB, Ostergren J, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006 27 : 65 75.
13. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol 1974 34 : 29 34.
14. Ministero della Salute DGdSI. Relazione sullo Stato Sanitario del Paese 2003-2004. Roma, Istituto Poligrafico e Zecca dello Stato, 2005, pp. 37 41.
15. Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, Pinkett T, et al. Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry. Am J Cardiol 1996 77 : 1017 1020.
16. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 : 2140 2150.
17. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: Prevalence, incidence, and risk factors. Diabetes Care 2001 24 : 1614 1619.
18. Fonarow GC, Adams KF Jr., Abraham WT, Yancy CW, Boscardin WJ, for the Adhere Scientific Advisory Committee. Risk stratification for in-hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis. JAMA 2005 293 : 572 580.
19. Gasparini M, Mantica M, Galimberti P, Genovese L, Pini D, Faletra F, La Marchesina U, et al. Is the outcome of cardiac resynchronization therapy related to the underlying etiology? Pacing Clin Electrophysiol 2003 26 : 175 180.
20. Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, Rouleau JL, et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 2000 21 : 1368 1375.
21. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003 107 : 3040 3046.
22. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A, Grobbee DE. The prognosis of heart failure in the general population. The Rotterdam Study. Eur Heart J 2001 22 : 1318 1327.
23. Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J, for the Multiple Risk Factor Intervention Trial Research G. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the multiple risk factor intervention trial. Arch Intern Med 2004 164 : 1438 1443.
24. Fantoni C, Regoli F, Ghanem A, Raffa S, Klersy C, Sorgente A, Faletra F, et al. Long-term outcome in diabetic heart failure patients with cardiac resynchronization therapy. Eur J Heart Fail 2008 10 : 298 307.